Poxel SA Financials
| POXEL Stock | EUR 0.23 0.01 4.17% |
Poxel |
Understanding current and past Poxel SA Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Poxel SA's financial statements are interrelated, with each one affecting the others. For example, an increase in Poxel SA's assets may result in an increase in income on the income statement.
Poxel SA Stock Summary
Poxel SA competes with Biomerieux, Eurofins Scientific, Sartorius Stedim, and SEB SA. Poxel SA, a biopharmaceutical company, develops drugs for metabolic diseases with a primary focus on type II diabetes. The company was founded in 2009 and is headquartered in Lyon, France. Poxel SA operates under Pharmaceuticals And Biosciences classification in France and is traded on Paris Stock Exchange. It employs 33 people.| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0012432516 |
| Business Address | Immeuble Le Sunway, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.poxelpharma.com |
| Phone | 33 4 37 37 20 10 |
| Currency | EUR - Euro |
You should never invest in Poxel SA without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Poxel Stock, because this is throwing your money away. Analyzing the key information contained in Poxel SA's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Poxel SA Key Financial Ratios
Poxel SA's financial ratios allow both analysts and investors to convert raw data from Poxel SA's financial statements into concise, actionable information that can be used to evaluate the performance of Poxel SA over time and compare it to other companies across industries.Poxel Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Poxel SA's current stock value. Our valuation model uses many indicators to compare Poxel SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Poxel SA competition to find correlations between indicators driving Poxel SA's intrinsic value. More Info.Poxel SA is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Poxel SA's earnings, one of the primary drivers of an investment's value.Poxel SA Systematic Risk
Poxel SA's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Poxel SA volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Poxel SA correlated with the market. If Beta is less than 0 Poxel SA generally moves in the opposite direction as compared to the market. If Poxel SA Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Poxel SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Poxel SA is generally in the same direction as the market. If Beta > 1 Poxel SA moves generally in the same direction as, but more than the movement of the benchmark.
Poxel SA November 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Poxel SA help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Poxel SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Poxel SA based on widely used predictive technical indicators. In general, we focus on analyzing Poxel Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Poxel SA's daily price indicators and compare them against related drivers.
| Information Ratio | (0.32) | |||
| Maximum Drawdown | 30.81 | |||
| Value At Risk | (5.13) | |||
| Potential Upside | 5.26 |
Additional Tools for Poxel Stock Analysis
When running Poxel SA's price analysis, check to measure Poxel SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Poxel SA is operating at the current time. Most of Poxel SA's value examination focuses on studying past and present price action to predict the probability of Poxel SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Poxel SA's price. Additionally, you may evaluate how the addition of Poxel SA to your portfolios can decrease your overall portfolio volatility.